Express Pharma: Zim Laboratories eyes regulated markets

Nagpur-based Zim Laboratories will invest Rs 35 crores for setting up research lab and small manufacturing unit in Nagpur both for the regulated and Rest of the World (RoW) markets. Funds will be arranged from internal accrual and term loans. Both the new units are likely to be commissioned in next six months.
On the sidelines of a press conference in Mumbai, Dr Anwar Daud, MD, Zim Laboratories said, “Our new research lab will specialise in complex generics and we will hire around 45-50 scientists. We will also set up a small batch manufacturing unit for high value and small volume formulation facility, which will be EU-GMP compliant.”

Popular posts from this blog

ZIMLab's Dr.Nidhi Sapkal delivered talk on "Technology development of Bi/Multilayer thin films" at International Conference on Pharmaceutical Development and Technology,Osaka, Japan.

ZIM Lab announces approval for Vitamin D3 Orally Disintegrating Film

ZIM Laboratories’ Clonazepam Orally Disintegrating Strips Receive Market Approval